InterCure (INCR)
(Delayed Data from NSDQ)
$2.64 USD
-0.03 (-1.12%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $2.64 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for InterCure Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 74 | 67 | -99,999 | -99,999 |
Receivables | NA | 40 | 16 | NA | NA |
Notes Receivable | NA | 0 | 0 | NA | NA |
Inventories | NA | 38 | 21 | NA | NA |
Other Current Assets | NA | 0 | 0 | NA | NA |
Total Current Assets | NA | 151 | 104 | NA | NA |
Net Property & Equipment | NA | 31 | 27 | NA | NA |
Investments & Advances | NA | 13 | 1 | NA | NA |
Other Non-Current Assets | NA | 0 | 0 | NA | NA |
Deferred Charges | NA | 6 | 1 | NA | NA |
Intangibles | NA | 85 | 80 | NA | NA |
Deposits & Other Assets | NA | 0 | 0 | NA | NA |
Total Assets | NA | 285 | 212 | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | NA | 38 | 22 | NA | NA |
Accounts Payable | NA | 38 | 20 | NA | NA |
Current Portion Long-Term Debt | NA | 0 | 1 | NA | NA |
Current Portion Capital Leases | NA | 0 | 0 | NA | NA |
Accrued Expenses | NA | 0 | 0 | NA | NA |
Income Taxes Payable | NA | 0 | 0 | NA | NA |
Other Current Liabilities | NA | 17 | 18 | NA | NA |
Total Current Liabilities | NA | 93 | 60 | NA | NA |
Mortgages | NA | 0 | 0 | NA | NA |
Deferred Taxes/Income | NA | 0 | 0 | NA | NA |
Convertible Debt | NA | 0 | 0 | NA | NA |
Long-Term Debt | NA | 30 | 4 | NA | NA |
Non-Current Capital Leases | NA | 7 | 7 | NA | NA |
Other Non-Current Liabilities | NA | 0 | 0 | NA | NA |
Minority Interest (Liabilities) | NA | 0 | 0 | NA | NA |
Total Liabilities | NA | 130 | 70 | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | NA | NA |
Common Stock (Par) | NA | 188 | 193 | NA | NA |
Capital Surplus | NA | 1 | 1 | NA | NA |
Retained Earnings | NA | -42 | -58 | NA | NA |
Other Equity | NA | 9 | 6 | NA | NA |
Treasury Stock | NA | 0 | 0 | NA | NA |
Total Shareholder's Equity | NA | 155 | 142 | NA | NA |
Total Liabilities & Shareholder's Equity | NA | 285 | 212 | NA | NA |
Total Common Equity | 0 | 155 | 142 | 0 | 0 |
Shares Outstanding | 45.50 | 42.70 | 42.70 | NA | NA |
Book Value Per Share | 0.00 | 3.64 | 3.33 | 0.00 | 0.00 |
Fiscal Year End for InterCure Ltd falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | -99,999 | 32 | 34 |
Receivables | NA | NA | NA | 37 | 48 |
Notes Receivable | NA | NA | NA | NA | 0 |
Inventories | NA | NA | NA | 39 | 39 |
Other Current Assets | NA | NA | NA | NA | 0 |
Total Current Assets | NA | NA | NA | 108 | 121 |
Net Property & Equipment | NA | NA | NA | 27 | 29 |
Investments & Advances | NA | NA | NA | 12 | 12 |
Other Non-Current Assets | NA | NA | NA | NA | 0 |
Deferred Charges | NA | NA | NA | 6 | 6 |
Intangibles | NA | NA | NA | 78 | 80 |
Deposits & Other Assets | NA | NA | NA | NA | 0 |
Total Assets | NA | NA | NA | 231 | 248 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | 15 | 0 |
Accounts Payable | NA | NA | NA | 29 | 28 |
Current Portion Long-Term Debt | NA | NA | NA | 0 | 21 |
Current Portion Capital Leases | NA | NA | NA | NA | 0 |
Accrued Expenses | NA | NA | NA | NA | 0 |
Income Taxes Payable | NA | NA | NA | NA | 0 |
Other Current Liabilities | NA | NA | NA | 13 | 16 |
Total Current Liabilities | NA | NA | NA | 57 | 66 |
Mortgages | NA | NA | NA | NA | 0 |
Deferred Taxes/Income | NA | NA | NA | NA | 0 |
Convertible Debt | NA | NA | NA | NA | 0 |
Long-Term Debt | NA | NA | NA | 23 | 27 |
Non-Current Capital Leases | NA | NA | NA | 6 | 6 |
Other Non-Current Liabilities | NA | NA | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | NA | NA | 0 |
Total Liabilities | NA | NA | NA | 86 | 100 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | NA | 0 |
Common Stock (Par) | NA | NA | NA | 174 | 179 |
Capital Surplus | NA | NA | NA | 1 | 1 |
Retained Earnings | NA | NA | NA | -37 | -40 |
Other Equity | NA | NA | NA | 8 | 8 |
Treasury Stock | NA | NA | NA | NA | 0 |
Total Shareholder's Equity | NA | NA | NA | 145 | 148 |
Total Liabilities & Shareholder's Equity | NA | NA | NA | 231 | 248 |
Total Common Equity | 0 | 0 | 0 | 100,144 | 148 |
Shares Outstanding | 45.50 | 45.50 | 45.50 | 45.50 | 42.70 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 2,200.96 | 3.47 |